Clinical trial · Observational

Prognostic Effect of Body Composition in Cancer Survivors

The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors

NCT06398782CI-TRIAL-00076710completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.

Conditions

Conditions (3)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Body Composition	—	UNRESOLVED	—
Cancer Survivor	—	UNRESOLVED	—
Morality	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
body composition assessment	Device	—	UNRESOLVED

Design

Arms and outcomes

Arms (0)

[]

Primary outcomes (2)

measure
Rate of all-cause mortality
timeFrame
Jan 1 1999 to Dec 31 2019
description
To evaluate the association between fat mass index (FMI, fat mass and height will be combined to report FMI in kg/m\^2) and all-cause mortality among cancer survivors.
measure
Rate of all-cause mortality
timeFrame
Jan 1 1999 to Dec 31 2019
description
To evaluate the association between muscle mass index (MMI, muscle mass and height will be combined to report MMI in kg/m\^2) and all-cause mortality among cancer survivors.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* Participants with cancer diagnosis beyond 18 years old.

Exclusion Criteria:

* Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.

References

Publications (0)

Data not yet available

No reference posted for this study.